Vera Ulrike Bacher (Vera Ulrike, Ulrike Bacher)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 57

Top Venues

Cancers

Hematological oncology

Journal of clinical medicine

International journal of molecular sciences

Inselspital Universitätsspital Bern

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Inselspital Universitätsspital Bern

Switzerland

Head physician :: Hematology

Publications

Valerie Wittibschlager, Vera Ulrike Bacher, Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences 24 (6) (2023)
Valerie Wittibschlager, Vera Ulrike Bacher, Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences 24 (6) (2023)
Alexander D Heini, Vera Ulrike Bacher, Thomas Pabst
Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL). British journal of haematology (2023)
Vera Ulrike Bacher, Evgenii Shumilov, Thomas Pabst
Benefit of repeated COVID-19 vaccination for patients with B-cell malignancies. British journal of haematology (2023)
Katja Seipel, Mariesol Abbühl, Vera Ulrike Bacher, Henning Nilius, Michael Daskalakis, Thomas Pabst
Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy. Cancers 15 (11) (2023)
Valerie Wittibschlager, Vera Ulrike Bacher, Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences 24 (6) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Roni Tamari, Donal P McLornan, Kwang Woo Ahn, Noel Estrada-Merly, Juan Carlos Carlos Hernández-Boluda, Sergio A Giralt, Jeanne M Palmer, Robert Peter Gale, Zachariah DeFilipp, David Marks, Marjolein W M van der Poel, Leo F Verdonck, Minoo Battiwalla, Miguel A Díaz, Vikas K Gupta, Haris Ali, Mark R Litzow, Hillard M Lazarus, Usama Gergis, Asad Bashey, Jane L Liesveld, Shahrukh K. Hashmi, Jeffrey J Pu, Amer Beitinjaneh, Christopher N Bredeson, David A Rizzieri, Bipin N Savani, Muhammad Bilal Abid, Siddhartha Ganguly, Vaibhav Agrawal, Vera Ulrike Bacher, Baldeep Wirk, Tania Jain, Corey S Cutler, Mahmoud Aljurf, Tamila Kindwall-Keller, Mohamed A Kharfan-Dabaja, Gerhard C Hildebrandt, Attaphol Pawarode, Melhem M Solh, Jean A Yared, Michael R Grunwald, Sunita Nathan, Taiga Nishihori, Sachiko Seo, Bart L Scott, Ryotaro Nakamura, Betul Oran, Tomasz Czerw, Ibrahim Yakoub Agha, Wael Saber
A Simple Prognostic System in Myelofibrosis Patients Undergoing Allogeneic Stem Cell Transplant: A CIBMTR/EBMT analysis. Blood advances (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Alexander D Heini, Philipp Beck, Vera Ulrike Bacher, Katja Seipel, Thilo Zander, Michael Daskalakis, Thomas Pabst
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia. Journal of clinical medicine 12 (6) (2023)
Vera Ulrike Bacher, Evgenii Shumilov, Thomas Pabst
Increasing insight in the value of repetitive COVID-19 vaccination in patients with haematological malignancies in the Omicron era. British journal of haematology (2023)
Alexander D Heini, Philipp Beck, Vera Ulrike Bacher, Katja Seipel, Thilo Zander, Michael Daskalakis, Thomas Pabst
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia. Journal of clinical medicine 12 (6) (2023)
Selina Bühler, Dilara Akhoundova, Barbara Jeker, Myriam Legros, Katja Seipel, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma. Cancers 15 (2) (2023)
Alexander D Heini, Philipp Beck, Vera Ulrike Bacher, Katja Seipel, Thilo Zander, Michael Daskalakis, Thomas Pabst
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia. Journal of clinical medicine 12 (6) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Fabrizio Huwyler, Rebekka Kunz, Vera Ulrike Bacher, Michèle Hoffmann, Urban Novak, Michael Daskalakis, Yara Banz, Thomas Pabst
Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma. Cancers 15 (7) (2023)
Camille Perroud, Dario Thurian, Martin Andres, Arnaud Künzi, Gertrud Wiedemann, Sacha Zeerleder, Vera Ulrike Bacher, Thomas Pabst, Yara Banz, Naomi Porret, Ekaterina Rebmann
Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma. Hematological oncology (2023)
Katja Seipel, Scarlett Kohler, Vera Ulrike Bacher, Thomas Pabst
HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology 45 (9) (2023)
Cédric Gillich, Dilara Akhoundova, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Katja Seipel, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma. Cancers 15 (10) (2023)
Selina Bühler, Dilara Akhoundova, Barbara Jeker, Myriam Legros, Katja Seipel, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma. Cancers 15 (2) (2023)
Evgenii Shumilov, Lena Aperdannier, Nicole Schmidt, Christoph Szuszies, Albrecht Neesse, Petra Hoffknecht, Cyrus Khandanpour, Jan-Henrik Mikesch, Matthias Stelljes, Göran Ramin Boeckel, Phil-Robin Tepasse, Lea Reitnauer, Raphael Koch, Justin Hasenkamp, Vera Ulrike Bacher, Simone Scheithauer, Lorenz Trümper, Norbert Schmitz, Gerald Wulf, Andrea Kerkhoff, Georg Lenz, Carolin Krekeler, Annalen Bleckmann
Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis. Cancers 14 (15) (2022)
Christian Rausch, Vera Ulrike Bacher, Manuela Rabaglio, Corinne Vorburger, Anke Klingenberg, Yara Banz, Michael Daskalakis, Thomas Pabst
Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study. Journal of clinical medicine 11 (18) (2022)
Jeanne Bohler, Vera Ulrike Bacher, Yara Banz, Raphael Stadelmann, Michael Medinger, Thilo Zander, Thomas Pabst
Blinatumomab in Relapsed/Refractory Burkitt Lymphoma. Cancers 15 (1) (2022)
Alexander D Heini, Vera Ulrike Bacher, Naomi A Porret, Gertrud Wiedemann, Myriam Legros, Denise Stalder Zeerleder, Katja Seipel, Urban Novak, Michael Daskalakis, Thomas Pabst
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. Cells 11 (17) (2022)
Carolin Krekeler, Lea Reitnauer, Vera Ulrike Bacher, Cyrus Khandanpour, Leander Steger, Göran Ramin Boeckel, Justine Klosner, Phil-Robin Tepasse, Marcel Kemper, Marc Tim Hennies, Rolf Mesters, Matthias Stelljes, Norbert Schmitz, Andrea Kerkhoff, Christoph Schliemann, Jan-Henrik Mikesch, Nicole Schmidt, Georg Lenz, Annalen Bleckmann, Evgenii Shumilov
Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario. Cancers 14 (22) (2022)
Ekaterina Gurevich, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Behrouz Mansouri Taleghani, Vera Ulrike Bacher, Thomas Pabst
Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML. Cancers 14 (4) (2022)
Jeanne Bohler, Vera Ulrike Bacher, Yara Banz, Raphael Stadelmann, Michael Medinger, Thilo Zander, Thomas Pabst
Blinatumomab in Relapsed/Refractory Burkitt Lymphoma. Cancers 15 (1) (2022)
Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst
sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma. Current issues in molecular biology 44 (4) (2022)
Katja Seipel, Yvo Brügger, Harpreet Mandhair, Vera Ulrike Bacher, Thomas Pabst
Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia. International journal of molecular sciences 23 (20) (2022)
Jeanne Bohler, Vera Ulrike Bacher, Yara Banz, Raphael Stadelmann, Michael Medinger, Thilo Zander, Thomas Pabst
Blinatumomab in Relapsed/Refractory Burkitt Lymphoma. Cancers 15 (1) (2022)
Tanja Stoffel, Vera Ulrike Bacher, Yara Banz, Michael Daskalakis, Urban Novak, Thomas Pabst
BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study. Journal of clinical medicine 11 (13) (2022)
Simona Gössi, Vera Ulrike Bacher, Claudia Haslebacher, Michael Nagler, Franziska Suter, Cornelia Staehelin, Urban Novak, Thomas Pabst
Humoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell Therapy. Cancers 14 (14) (2022)
Jeanne Bohler, Vera Ulrike Bacher, Yara Banz, Raphael Stadelmann, Michael Medinger, Thilo Zander, Thomas Pabst
Blinatumomab in Relapsed/Refractory Burkitt Lymphoma. Cancers 15 (1) (2022)
Evgenii Shumilov, Paolo Mazzeo, Martin S Zinkernagel, Myriam Legros, Naomi Porret, Lorenz Romagna, Detlef Haase, Georg Lenz, Urban Novak, Yara Banz, Thomas Pabst, Vera Ulrike Bacher
Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology. Current oncology (Toronto, Ont.) 29 (2) (2022)
Vera Rentsch, Katja Seipel, Yara Banz, Gertrud Wiedemann, Naomi A Porret, Vera Ulrike Bacher, Thomas Pabst
Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy. Cancers 14 (10) (2022)
Melanie Maechler, Vera Ulrike Bacher, Michael Daskalakis, Henning Nilius, Michael Nagler, Behrouz Mansouri Taleghani, Barbara Jeker, Thomas Pabst
Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients. Hematological oncology (2022)
Katja Seipel, Basil Kopp, Vera Ulrike Bacher, Thomas Pabst
BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia. Cancers 13 (3) (2021)
Nicolas Bonadies, Alicia Rovo, Naomi Porret, Vera Ulrike Bacher
When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to Diagnosis. Journal of clinical medicine 10 (5) (2021)
Evgenii Shumilov, Petra Hoffknecht, Raphael Koch, Rudolf Peceny, Steffen Voigt, Nicole Schmidt, Micha Peeck, Vera Ulrike Bacher, Simone Scheithauer, Lorenz Trümper, Georg Lenz, Andrea Kerkhoff, Annalen Bleckmann
Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers. Cancers 13 (12) (2021)
Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait, Jonathan Sanchez, Hai-Lin Wang, Mahmoud Aljurf, Amer Assal, Vera Ulrike Bacher, Sherif M Badawy, Nelli Bejanyan, Vijaya Raj Bhatt, Christopher N Bredeson, Michael Byrne, Paul Castillo, Jan Cerny, Saurabh Chhabra, Stefan Octavian Ciurea, Zachariah DeFilipp, Nosha Farhadfar, Shahinaz M Gadalla, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael Richard Grunwald, Shahrukh K. Hashmi, Gerhard Carl Hildebrandt, Christopher G Kanakry, Ankit Kansagra, Farhad Khimani, Maxwell M Krem, Hillard M Lazarus, Hongtao Liu, Rodrigo Martino Bofarull, Fotios V Michelis, Sunita Nathan, Taiga Nishihori, Richard F Olsson, Ran Reshef, David A Rizzieri, Jacob M Rowe, Bipin P Savani, Sachiko Seo, Akshay Sharma, Melhem Solh, Celalettin Ustun, Leo F Verdonck, Christopher S Hourigan, Brenda M Sandmaier, Mark R Litzow, Partow Kebriaei, Daniel J Weisdorf, Yanming Zhang, Martin S Tallman, Wael Saber
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood advances (2021)
Katja Seipel, Carolyn Graber, Laura Flückiger, Vera Ulrike Bacher, Thomas Pabst
Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia. International journal of molecular sciences 22 (15) (2021)
Ioannis Chanias, Kristina Stojkov, Gregor Th Stehle, Michael Daskalakis, Helena Simeunovic, Linet Muthoni Njue, Annatina S Schnegg-Kaufmann, Naomi A Porret, Ramanjaneyulu Allam, Tata Nageswara Rao, Rudolf Benz, Axel Ruefer, Adrian Schmidt, Marcel Adler, Alicia Rovo, Stefan Balabanov, Georg Stussi, Vera Ulrike Bacher, Nicolas Bonadies, null On Behalf Of The Swiss Mds Study Group
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine. Cancers 13 (13) (2021)
Anina Mathys, Vera Ulrike Bacher, Yara Banz, Myriam Legros, Behrouz Mansouri Taleghani, Urban Novak, Thomas Pabst
Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre-CAR T-cell era. Hematological oncology (2021)
Johannes R Graf, Stefan Forster, Frido K Bruehl, Yara Banz, Mahmoud Hallal, Justine Brodard, Vera Ulrike Bacher, Ramanjaneyulu Allam, Christian M Schürch, Nicolas Bonadies
Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes. Cancers 13 (22) (2021)
Anna Nydegger, Urban Novak, Marie-Noëlle Kronig, Myriam Legros, Sacha Zeerleder, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients. Cancers 13 (23) (2021)
Matthew J Wieduwilt, Leland Metheny, Mei-Jie Zhang, Hai-Lin Wang, Noel Estrada-Merly, David I Marks, A Samar Al-Homsi, Lori S Muffly, Nelson J Chao, David A Rizzieri, Robert Peter Gale, Shahinaz M Gadalla, Mitchell S Cairo, Alberto Mussetti, Steven D Gore, Vijaya Raj Bhatt, Sagar S Patel, Fotios V Michelis, Yoshihiro Inamoto, Sherif M Badawy, Edward Copelan, Neil Palmisiano, Mohamed A Kharfan-Dabaja, Hillard M Lazarus, Siddhartha Ganguly, Christopher N Bredeson, Miguel Angel Diaz Perez, Ryan Cassaday, Bipin P Savani, Karen Kuhn Ballen, Rodrigo Martino Bofarull, Baldeep Wirk, Vera Ulrike Bacher, Mahmoud Aljurf, Asad Bashey, Hemant S Murthy, Jean A Yared, Ibrahim Aldoss, Nosha Farhadfar, Hongtao Liu, Hisham Abdel-Azim, Edmund K Waller, Melhem Solh, Matthew Seftel, Marjolein W M van der Poel, Michael Richard Grunwald, Jane L Liesveld, Rammurti T Kamble, Joseph P McGuirk, Reinhold Munker, Jean-Yves Cahn, Jong Wook Lee, Cesar O Freytes, Maxwell M Krem, Lena E Winestone, Usama Gergis, Sunita Nathan, Richard F Olsson, Leo F Verdonck, Akshay Sharma, Olle Ringdén, Brian D Friend, Jan Cerny, Hannah K Choe, Saurabh Chhabra, Taiga Nishihori, Sachiko Seo, Biju George, Lee Ann Baxter-Lowe, Gerhard Carl Hildebrandt, Marcos J deLima, Mark R Litzow, Partow Kebriaei, Christopher S Hourigan, Muhammad Bilal Abid, Daniel J Weisdorf, Wael Saber
Haploidentical vs. sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia. Blood advances (2021)
Alexander D Heini, Naomi A Porret, Reinhard Zenhaeusern, Annette Winkler, Vera Ulrike Bacher, Thomas Pabst
Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML. Cancers 13 (13) (2021)
Christophe Betticher, Vera Ulrike Bacher, Myriam Legros, Stefan Zimmerli, Yara Banz, Behrouz Mansouri Taleghani, Thomas Pabst
Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation. Hematological oncology 39 (1) (2020)
Johanna Flach, Evgenii Shumilov, Gertrud Wiedemann, Naomi Porret, Inna Shakhanova, Susanne Bürki, Myriam Legros, Raphael Joncourt, Thomas Pabst, Vera Ulrike Bacher
Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia. Hematological oncology 38 (4) (2020)
Florian Eicher, Behrouz Mansouri Taleghani, Christof Schild, Vera Ulrike Bacher, Thomas Pabst
Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels. Hematological oncology 38 (4) (2020)
Jeffrey R Idle, Katja Seipel, Vera Ulrike Bacher, Thomas Pabst, Diren Beyoğlu
(2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia. Cancers 12 (10) (2020)
Ioannis Chanias, C Matthias Wilk, Rudolf Benz, Michael Daskalakis, Georg Stussi, Adrian Schmidt, Vera Ulrike Bacher, Nicolas Bonadies, null On Behalf Of The Swiss Mds Study Group
Survey on Recommended Health Care for Adult Patients with Myelodysplastic Syndromes Identifies Areas for Improvement. International journal of environmental research and public health 17 (24) (2020)
Alexander D Heini, Rebecca Hugo, Martin D Berger, Urban Novak, Vera Ulrike Bacher, Thomas Pabst
Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia. Hematological oncology 38 (1) (2019)
Evgenii Shumilov, Johanna Flach, Raphael Joncourt, Naomi Porret, Gertrud Wiedemann, Anne Angelillo-Scherrer, Lorenz Trümper, Martin Fiedler, Barbara Jeker, Ursula Amstutz, Thomas Pabst, Vera Ulrike Bacher
Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations. Hematological oncology 37 (3) (2019)
Sebastian Moser, Vera Ulrike Bacher, Barbara Jeker, Behrouz Mansouri Taleghani, Daniel Betticher, Axel Ruefer, Thomas Egger, Urban Novak, Thomas Pabst
Autologous stem cell transfusions on multiple days in patients with multiple myeloma-Does it matter? Hematological oncology 37 (5) (2019)
Johanna Flach, Evgenii Shumilov, Raphael Joncourt, Naomi Porret, Joëlle Tchinda, Myriam Legros, Ilaria Scarpelli, Ekkehard Hewer, Urban Novak, Jacqueline Schoumans, Vera Ulrike Bacher, Thomas Pabst
Detection of rare reciprocal RUNX1 rearrangements by next-generation sequencing in acute myeloid leukemia. Genes, chromosomes & cancer 59 (4) (2019)

Vera Ulrike Bacher.css-eqlu8i{font-size:small;padding-left:4px;} (Vera Ulrike, Ulrike Bacher)

Publication Activity (10 Years)

Top Topics

Top Venues

Vera Ulrike Bacher (Vera Ulrike, Ulrike Bacher)